HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Complaints Allege Guthy-Renker’s WEN Conditioner Line Causes Hair Loss

This article was originally published in The Rose Sheet

Executive Summary

A suit filed March 17 alleges the products cause extreme and possibly permanent damage to hair, including hair loss, visible bald spots and severe breakage. In an earlier suit, the firm argued that a mandatory agreement requires customers to submit claims to binding individual arbitration rather than proceeding in court.

You may also be interested in...

FDA Tests WEN Conditioner’s MI/MCI Content In Pursuit Of Hair-Loss Answers

The MI/MCI preservative combination is a suspect being explored by FDA as part of its investigation into reports of hair loss and other adverse effects linked to WEN Cleansing Conditioners. The agency discusses testing it undertook to quantitate the WEN products’ MI/MCI content in a response to concerns raised by Democratic Congressman Frank Pallone of New Jersey.

FDA To Congressman Pallone: Probe Into WEN Conditioner AEs Continues

FDA’s investigation is “active and ongoing” into AE reports linking WEN Cleansing Conditioners to hair loss, irritation and rashes. In a letter obtained by the Rose Sheet through a Freedom of Information Act request, the agency addresses questions posed by Democratic Congressman Frank Pallone regarding its regulatory response to date and related exchanges with manufacturer Guthy-Renker and creator Chaz Dean.

FDA: EOS Lip Balms Linked To Adverse Reactions, But Cause Is Unknown

In a March 16 post to its website, FDA says that after inspecting EOS Products' contract manufacturer, it still cannot determine why consumers are experiencing rashes, blisters and cracked lips following use of EOS Lip Balm.

Related Content

Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts